Zhejiang Taimei Medical Technology Co Ltd
F:A2V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Taimei Medical Technology Co Ltd
F:A2V
|
CN |
|
NEXE Innovations Inc
F:NX5
|
CA |
|
S
|
Stelrad Group PLC
F:6OJ
|
UK |
|
P
|
Patrick Industries Inc
F:PK2
|
US |
|
U
|
Ucb SA
F:UNC0
|
BE |
|
I
|
Ironwood Pharmaceuticals Inc
F:I76
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A2V's stock price target?
Not Available
A2V does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Zhejiang Taimei Medical Technology Co Ltd?
Projected CAGR
12%
Over the last 3 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 12%.